A, Groups of 4 naïve BALB/c mice were injected intradermally with recombinant murine IL-17 (0.5 μg/mouse) of into ear skin on 3 consecutive days. On day 5, inflammatory ear cells were isolated and DC and neutrophils identified by FACS staining with anti-CD11c, anti-NIMP and anti-Gr-1, as appropriate (n=8, *=p ≤ 0.05, ***=p ≤ 0.002). B, C57BL/6 mice were infected with 2 × 105 parasites and treated with 0.5 or 1 μg of rIL-17A as indicated every second day starting on d7 until d19. Lesions are expressed as mean ± SEM, n=2.